The Clinical Efficacy of Combination Nebulized Anticholinergic and Adrenergic Bronchodilators vs Nebulized Adrenergic Bronchodilator Alone in Acute Asthma
- 1 February 1997
- Vol. 111 (2) , 311-315
- https://doi.org/10.1378/chest.111.2.311
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The assessment and treatment of asthma: A conference reportJournal of Allergy and Clinical Immunology, 1990
- NEBULISED SALBUTAMOL WITH AND WITHOUT IPRATROPIUM BROMIDE IN ACUTE AIRFLOW OBSTRUCTIONThe Lancet, 1989
- The Assessment and Management of Acute Life-Threatening AsthmaChest, 1989
- Comparison of Beta-Adrenergic Agents Delivered by Nebulizer vs Metered Dose Inhaler with InspirEase in Hospitalized Asthmatic PatientsChest, 1988
- Should Ipratropium Bromide be Added to Beta-Agonists in Treatment of Acute Severe Asthma?Chest, 1988
- Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and AsthmaAmerican Review of Respiratory Disease, 1987
- Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency roomThe American Journal of Medicine, 1987
- A place for ipratropium bromide in the treatment of severe acute asthmaRespiratory Medicine, 1985
- Comparison of nebulized salbutamol with nebulized ipratropium bromide in acute asthmaRespiratory Medicine, 1983
- Effect of outpatient treatment of asthma with beta agonists on the response to sympathomimetics in an emergency roomThe American Journal of Medicine, 1983